These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24284393)

  • 21. [The Propagation Hypothesis of Prion-like Protein Agregates in Neurodegenerative Diseases].
    Nonaka T
    Brain Nerve; 2019 Nov; 71(11):1209-1214. PubMed ID: 31722306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prion-like spread of protein aggregates in neurodegeneration.
    Polymenidou M; Cleveland DW
    J Exp Med; 2012 May; 209(5):889-93. PubMed ID: 22566400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Ritchie DL; Barria MA
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The Prion-like Mechanism in Neurodegenerative Diseases-Current Studies and Future Prospects].
    Tarutani A; Hisanaga SI; Hasegawa M
    Brain Nerve; 2016 Oct; 68(10):1197-1204. PubMed ID: 27703107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular Models for the Study of Prions.
    Holmes BB; Diamond MI
    Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 27815306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expanding realm of prion phenomena in neurodegenerative disease.
    Frost B; Diamond MI
    Prion; 2009; 3(2):74-7. PubMed ID: 19448400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prion-like propagation of protein aggregation and related therapeutic strategies.
    Kaufman SK; Diamond MI
    Neurotherapeutics; 2013 Jul; 10(3):371-82. PubMed ID: 23801258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prions and prion-like proteins.
    Fraser PE
    J Biol Chem; 2014 Jul; 289(29):19839-40. PubMed ID: 24860092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's disease as a member of Prion-like disorders.
    Herva ME; Spillantini MG
    Virus Res; 2015 Sep; 207():38-46. PubMed ID: 25456401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleic acid induced protein aggregation and its role in biology and pathology.
    Yin J; Chen R; Liu C
    Front Biosci (Landmark Ed); 2009 Jun; 14(13):5084-106. PubMed ID: 19482606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prion-like propagation of α-synuclein in neurodegenerative diseases.
    Tarutani A; Hasegawa M
    Prog Mol Biol Transl Sci; 2019; 168():323-348. PubMed ID: 31699325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of Tau and α-Synuclein Pathology in the Visual System.
    Rahimi J; Milenkovic I; Kovacs GG
    J Parkinsons Dis; 2015; 5(2):333-40. PubMed ID: 25737267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prions and Non-infectious Amyloids of Mammals - Similarities and Differences.
    Galkin AP; Velizhanina ME; Sopova YV; Shenfeld AA; Zadorsky SP
    Biochemistry (Mosc); 2018 Oct; 83(10):1184-1195. PubMed ID: 30472956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases.
    Walker LC
    Annu Rev Genet; 2016 Nov; 50():329-346. PubMed ID: 27893962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of cellular prion protein in interneuronal amyloid transmission.
    Del Río JA; Ferrer I; Gavín R
    Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is strain in neurodegenerative diseases?
    Tian Y; Meng L; Zhang Z
    Cell Mol Life Sci; 2020 Feb; 77(4):665-676. PubMed ID: 31531680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biochemistry of conformational transition and aggregation of amyloid proteins].
    Yanagawa H; Ogawa Y
    Uirusu; 2001 Dec; 51(2):163-70. PubMed ID: 11977757
    [No Abstract]   [Full Text] [Related]  

  • 39. A critical review of the prion hypothesis of human synucleinopathies.
    Tamgüney G; Korczyn AD
    Cell Tissue Res; 2018 Jul; 373(1):213-220. PubMed ID: 29116402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.